Oseltamivir-induced dyskinesia in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 17, Issue 2, 2011, Pages 133-134

  Kadowaki, Taro ^a   Komagamine, Tomoko ^a   Suzuki, Keisuke ^a   Hirata, Koichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Dyskinesia; Influenza; Oseltamivir; Parkinson's disease

Indexed keywords

CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; OSELTAMIVIR; PRAMIPEXOLE; SELEGILINE; ZONISAMIDE;

ABNORMAL BEHAVIOR; ADULT; AKINESIA; BRADYKINESIA; BRAIN DEPTH STIMULATION; CASE REPORT; DYSKINESIA; FEMALE; FOLLOW UP; HUMAN; INFLUENZA B; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS;

DYSKINESIAS; FEMALE; HUMANS; INFLUENZA, HUMAN; MIDDLE AGED; OSELTAMIVIR; PARKINSON DISEASE;

EID: 79551486656     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.10.013     Document Type: Letter

References (5)

1. Toovey S., Rayner C., Prinssen E., Chu T., Donner B., Thakrar B., et al. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review. Drug Saf 2008, 31:1097-1114.
2. Smith J.R., Sacks S. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. Int J Clin Pract 2009, 63:596-605.
3. Tanabe T., Hara K., Nakajima M., Shimakawa S., Tamai H. Oseltamivir treatment for children showing abnormal behavior during influenza virus infection. Brain Dev 2010, 32:440-444.
4. Yoshino T., Nisijima K., Shioda K., Yui K., Kato S. Oseltamivir (tamiflu) increases dopamine levels in the rat medial prefrontal cortex. Neurosci Lett 2008, 438:67-69.
5. Izumi Y., Tokuda K., O'Dell K., Zorumski C., Narahashi T. Synaptic and behavioral interactions of oseltamivir (tamiflu) with neurostimulants. Hum Exp Toxicol 2008, 27:911-917.